0001209191-16-147964.txt : 20161102
0001209191-16-147964.hdr.sgml : 20161102
20161102170426
ACCESSION NUMBER: 0001209191-16-147964
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161031
FILED AS OF DATE: 20161102
DATE AS OF CHANGE: 20161102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1208
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Fred M
CENTRAL INDEX KEY: 0001331339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 161968869
MAIL ADDRESS:
STREET 1: C/O BEJING MED-PHARM CORPORATION
STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-31
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001331339
Powell Fred M
C/O ANTARES PHARMA, INC.
100 PRINCETON STREET SOUTH, SUITE 300
EWING
NJ
08628
0
1
0
0
Senior Vice President & CFO
Stock Option (right to buy)
1.76
2016-10-31
4
A
0
150000
0.00
A
2026-10-31
Common Stock
150000
150000
D
Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
The options vest in equal quarterly installments over three years from the date of grant.
/s/ Peter J. Graham as attorney-in-fact for Fred M. Powell
2016-11-02
EX-24.4_681937
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
KNOW ALL PERSONS BY THESE PRESENTS, that I, Fred M. Powell, hereby constitute
and appoint Robert F. Apple, Peter J. Graham and Keith Muckenhirn, each of them,
my true and lawful attorneys-in-fact and agents, each acting alone, with full
powers of substitution and resubstitution for me and in my name, place and
stead, to sign any reports on Form 3 (Initial Statement of Beneficial
Ownership), Form 4 (Statement of Changes in Beneficial Ownership of Securities)
and Form 5 (Annual Statement of Changes in Beneficial Ownership) relating to
transactions by me in Common Stock or other securities of Antares Pharma, Inc.,
and all amendments thereto, and to file the same with the Securities and
Exchange Commission and appropriate securities listing agency, if required,
granting unto said attorneys-in-fact and agents, and each of them, or their
substitutes, full power and authority to do and perform each and every act and
thing requisite or necessary to be done, as fully to all intents and purposes as
I might or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, and each of them, or their substitutes, may
lawfully do or cause to be done by virtue hereof. This Power of Attorney shall
be effective until such time as I deliver a written revocation thereof to my
above-named attorneys-in-fact and agents.
Signed: /s/Fred M. Powell
Dated: October 31, 2016